ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신속 진단 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 이러한 예상 성장의 주요 원동력에는 개인 맞춤형 의료 서비스의 인기 상승, AI 기반 진단 도구의 구현 증가, 가정 내 테스트 옵션에 대한 소비자 선호도 증가, 의료 인프라 개발 확대, 팬데믹 대응 전략에 대한 강조 등이 있습니다. 예측 기간 중에 예상되는 현저한 동향에는 마이크로플루이딕스 기술의 강화, 바이오 센서 진단의 비약적 진보, 모바일 앱과 검사 툴의 통합, 랩 칩 혁신의 진전, 멀티플렉스 진단 플랫폼의 진화 등이 포함됩니다.
감염증의 만연이 신속한 진단 시장의 확대를 견인할 것으로 예측됩니다. 세계 여행 증가로 인해 감염이 빨라지고 감염률이 높아지고 있습니다. 예를 들어 2025년 5월 스위스에 본부를 두고 국제공중위생을 담당하는 유엔의 전문기관인 세계보건기구(WHO)는 2025년 2월 중순 이후 세계 SARS-CoV-2의 활동이 증가하고 있다고 보고했습니다. 센티넬 사이트의 데이터에 따르면, 검사 양성률은 11%에 달했으며, 이는 2024년 7월에 관측된 마지막 수준입니다.
신속 진단 시장의 주요 기업은 특히 포인트 오브 케어 환경에서 정밀도를 높이고 소요 시간을 단축하고 환자 케어를 개선하는 신속 진단 검사 툴의 개발에 있어서 기술 혁신과 진보를 우선하고 있습니다. SEKISUI Diagnostics는 호흡기 세포융합 바이러스(RSV)를 검출하도록 설계된 신속 진단 도구인 OSOM RSV 테스트를 발표했습니다. 이 검사는 전문적인 건강 관리 환경을 대상으로 하며, 단 15분 만에 결과를 얻을 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신속 진단 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 신속 진단 시장 : 성장률 분석
세계의 신속 진단 시장 실적 : 규모와 성장, 2019-2024
세계의 신속 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 신속 진단 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 신속 진단 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
키트
시약
기기
기타 제품 유형
세계의 신속 진단 시장 : 플랫폼별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
면역 측정
분자 검출
기타 신속 진단 플랫폼
세계의 신속 진단 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
혈당 검사
감염증 검사
심장 대사 검사
임신과 생식능력 검사
대변잠혈검사
응고 검사
독성시험
세계의 신속 진단 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
Brick And Mortar
전자상거래
기타 유통 채널
세계의 신속 진단 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
진단센터
재택 케어 설정
병원 약국
기타 최종 사용자
세계의 신속 진단 시장 : 키트별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
래터럴 플로우 분석 키트
PCR 키트
면역 측정 키트
Microfluidic 키트
분자진단 키트
멀티플렉스 키트
세계의 신속 진단 시장 : 시약별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
효소
버퍼
Probes And Primers
Stains And Dyes
항체
교정 및 컨트롤 시약
세계의 신속 진단 시장 : 상품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
PCR 기계
래터럴 플로우 리더
면역 측정 분석 장치
Microfluidic Analyzers
자동 샘플 처리 장치
바이오센서
세계의 신속 진단 시장 : 기타 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
소프트웨어 및 데이터 관리 도구
샘플 수집 장치
액세서리와 소모품
교정 표준
포인트 오브 케어 기기
제7장 지역별/국가별 분석
세계의 신속 진단 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 신속 진단 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
신속 진단 시장 : 경쟁 구도
신속 진단 시장 : 기업 프로파일
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthineers AG
Becton Dickinson and Company
Quest Diagnostics Incorporated
Hologic Inc.
bioMerieux SA
QuidelOrtho Corporation
Bio-Rad Laboratories Inc.
QIAGEN NV
Cepheid Inc.
OraSure Technologies Inc.
Nova Biomedical Corporation
Fujirebio Holdings Inc.
Sekisui Diagnostics LLC
EKF Diagnostics Holdings plc
Trinity Biotech plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
신속 진단 시장(2029년) : 새로운 기회를 제공하는 국가
신속 진단 시장(2029년) : 새로운 기회를 제공하는 부문
신속 진단 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Rapid diagnostics are medical tests designed to swiftly detect the presence or absence of specific pathogens, conditions, or biomarkers, typically providing results within minutes to a few hours. These tests are frequently utilized at the point of care, facilitating prompt clinical decisions, early intervention, and improved patient outcomes.
The main product types in rapid diagnostics include kits, reagents, instruments, and other related products. Kits are pre-assembled diagnostic tools that contain all necessary components-such as reagents, assay devices, and instructions-for conducting specific tests accurately and efficiently. Rapid diagnostics are performed using various platforms, including immunoassays, molecular detection methods, and other technologies. They are applied across a range of testing areas such as blood glucose monitoring, infectious disease screening, cardiometabolic testing, pregnancy and fertility testing, fecal occult blood testing, coagulation testing, and toxicology screening. These diagnostic tools are distributed through multiple channels, including hospital pharmacies, physical retail stores, e-commerce platforms, and other outlets. Key end users include diagnostic laboratories, homecare settings, hospital pharmacies, and other healthcare providers.
The rapid diagnostics market research report is one of a series of new reports from The Business Research Company that provides rapid diagnostics market statistics, including the rapid diagnostics industry global market size, regional shares, competitors with the rapid diagnostics market share, detailed rapid diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the rapid diagnostics industry. This rapid diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The rapid diagnostics market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $36.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. This historical growth was driven by the increasing burden of infectious diseases, expanding utilization of point-of-care diagnostics, growing issues with antimicrobial resistance, heightened awareness of early disease detection, and rising healthcare investments in developing nations.
The rapid diagnostics market size is expected to see rapid growth in the next few years. It will grow to $57.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. Key drivers for this projected growth include the rising popularity of personalized healthcare, growing implementation of AI-driven diagnostic tools, increasing consumer preference for at-home testing options, escalating healthcare infrastructure development, and a stronger emphasis on pandemic response strategies. Prominent trends anticipated during the forecast period encompass enhancements in microfluidic technologies, breakthroughs in biosensor diagnostics, integration of mobile apps with testing tools, progress in lab-on-a-chip innovations, and the evolution of multiplex diagnostic platforms.
The growing prevalence of infectious diseases is expected to drive the expansion of the rapid diagnostics market. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can spread from one person to another either directly or indirectly. The increase in infectious disease cases is largely attributed to greater global travel, which facilitates faster transmission and higher infection rates. Rapid diagnostics play a critical role by enabling the quick and accurate identification of pathogens, which supports timely treatment decisions, minimizes transmission, and improves patient outcomes. For example, in May 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, reported that global SARS-CoV-2 activity has been increasing since mid-February 2025. According to data from sentinel sites, the test positivity rate reached 11%, a level last observed in July 2024. As such, the rising prevalence of infectious diseases is contributing to the growth of the rapid diagnostics market.
Key players in the rapid diagnostics market are prioritizing innovation and advancements, particularly in the development of rapid diagnostic testing tools that enhance accuracy, reduce turnaround times, and improve patient care in point-of-care environments. Rapid diagnostic testing tools are medical devices that swiftly detect the presence of specific diseases or conditions, often delivering results within minutes. For example, in May 2025, SEKISUI Diagnostics, a US-based medical diagnostics manufacturer, introduced the OSOM RSV Test, a rapid diagnostic tool designed to detect respiratory syncytial virus (RSV). This test is intended for professional healthcare settings and provides results in just 15 minutes. It utilizes a rapid immunochromatographic assay to qualitatively detect RSV nucleoprotein antigen from anterior nasal swab specimens taken from symptomatic patients. The rapid results support timely and effective clinical decision-making.
In June 2023, Avacta Group, a UK-based biotechnology company, acquired Coris Bioconcept SRL for an undisclosed sum. With this acquisition, Avacta Group seeks to broaden its diagnostics portfolio and strengthen its capabilities in rapid testing technologies for infectious diseases and antimicrobial resistance. Coris Bioconcept SRL is a Belgium-based biotechnology firm specializing in the development, production, and marketing of rapid diagnostic tests.
Major players in the rapid diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Fujirebio Holdings Inc., Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA.
North America was the largest region in the rapid diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rapid diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the rapid diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rapid diagnostics market includes revenues earned by providing services such as quick and accurate testing for diseases, infections, and medical conditions using point-of-care diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The rapid diagnostics market consists of sales of quick diagnostic test kits and devices used for the rapid detection of diseases and medical conditions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rapid Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rapid diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rapid diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rapid diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Kits; Reagents; Instruments; Other Product Types
2) By Platform: Immunoassays; Molecular Detection; Other Rapid Diagnostic Platforms
4) By Other Product Types: Software and Data Management Tools; Sample Collection Devices; Accessories and Consumables; Calibration Standards; Point-of-Care Devices
Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Rapid Diagnostics Market Characteristics
3. Rapid Diagnostics Market Trends And Strategies
4. Rapid Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Rapid Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Rapid Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Rapid Diagnostics Market Growth Rate Analysis
5.4. Global Rapid Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Rapid Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Rapid Diagnostics Total Addressable Market (TAM)
6. Rapid Diagnostics Market Segmentation
6.1. Global Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits
Reagents
Instruments
Other Product Types
6.2. Global Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassays
Molecular Detection
Other Rapid Diagnostic Platforms
6.3. Global Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy And Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
6.4. Global Rapid Diagnostics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Brick And Mortar
E-Commerce
Other Distribution Channels
6.5. Global Rapid Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Centers
Homecare Settings
Hospital Pharmacies
Other End Users
6.6. Global Rapid Diagnostics Market, Sub-Segmentation Of Kits,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lateral Flow Assay Kits
PCR Kits
Immunoassay Kits
Microfluidic Kits
Molecular Diagnostic Kits
Multiplex Kits
6.7. Global Rapid Diagnostics Market, Sub-Segmentation Of Reagents,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzymes
Buffers
Probes And Primers
Stains And Dyes
Antibodies
Calibration And Control Reagents
6.8. Global Rapid Diagnostics Market, Sub-Segmentation Of Instruments,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR Machines
Lateral Flow Readers
Immunoassay Analyzers
Microfluidic Analyzers
Automated Sample Processors
Biosensors
6.9. Global Rapid Diagnostics Market, Sub-Segmentation Of Other Product Types,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software And Data Management Tools
Sample Collection Devices
Accessories And Consumables
Calibration Standards
Point-Of-Care Devices
7. Rapid Diagnostics Market Regional And Country Analysis
7.1. Global Rapid Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Rapid Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
